HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of L-627, a new carbapenem, in the treatment of experimentally induced intra-abdominal infections in rats.

Abstract
A reproducible experimental model of intra-abdominal infections in rats has been devised in order to simulate intra-abdominal sepsis in patients. Pre-operatively, the rats were fed lean ground beef for two weeks in order to change the intestinal flora to one similar to that of humans. A 1-cm segment of ileum was isolated on its vascular pedicle. The intestine was then divided at each end of the segment and intestinal continuity was re-established by an end-to-end anastomosis. The segment of ileum was then returned to the abdominal cavity. This experimental model was used to compare the efficacy of L-627 with the combination of gentamicin plus metronidazole. Eighty per cent of the untreated animals died within three days. Animals treated with L-627 or gentamicin plus metronidazole had significantly decreased mortality and increased cure rates during the experimental period. Only two animals in the two treatment groups died. L-627 seems to be as useful as gentamicin plus metronidazole in the treatment of intra-abdominal infections.
AuthorsC E Nord, G Lahnborg
JournalDrugs under experimental and clinical research (Drugs Exp Clin Res) Vol. 18 Issue 10 Pg. 411-4 ( 1992) ISSN: 0378-6501 [Print] Switzerland
PMID1306152 (Publication Type: Journal Article)
Chemical References
  • Carbapenems
  • Gentamicins
  • Thienamycins
  • Metronidazole
  • biapenem
Topics
  • Abdomen
  • Animals
  • Bacterial Infections (drug therapy, microbiology)
  • Carbapenems (therapeutic use)
  • Disease Models, Animal
  • Gentamicins (therapeutic use)
  • Intestines (physiology, surgery)
  • Male
  • Metronidazole (therapeutic use)
  • Rats
  • Rats, Sprague-Dawley
  • Thienamycins (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: